“There’s little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs … More
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to…
“There’s little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs … More
The Federal Trade Commission and U.S. Department of Justice recently kicked off a series of listening sessions to examine barriers to…